Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy
- PMID: 23313568
- DOI: 10.1016/j.clon.2012.11.010
Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy
Abstract
Aims: To carry out a meta-analysis to assess the effectiveness of magnetic resonance imaging (MRI) during the follow-up of patients with prostate cancer after undergoing external beam radiotherapy (EBRT) or radical prostatectomy.
Materials and methods: MEDLINE, EMBASE and other databases were searched for relevant original articles published from January 1995 to October 2011. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool. Pooled estimation and subgroup analysis data were obtained by statistical analysis.
Results: Fourteen of 768 initially identified studies were included in the meta-analysis. Seven studies examining patient after radical prostatectomy had a pooled sensitivity and specificity on the patient level of 82% (95% confidence interval 78-86%) and 87% (95% confidence interval 81-92%), respectively. In the subgroup analysis, compared with T2-weighted imaging (T2WI), dynamic contrast-enhanced (DCE) MRI showed higher pooled sensitivity (85%, 95% confidence interval 78-90%) and specificity (95%, 95% confidence interval 88-99%). DCE MRI combined with magnetic resonance spectroscopic imaging (1H-MRSI) had the highest pooled sensitivity (92%, 95% confidence interval 83-97%). Nine studies examining men after EBRT had a pooled sensitivity and specificity on the patient level of 82% (95% confidence interval 75-88%) and 74% (95% confidence interval 64-82%), respectively. Compared with T2WI, DCE MRI showed higher pooled sensitivity (90%, 95% confidence interval 77-97%) and specificity (81%, 95% confidence interval 64-93%). DCE combined with 1H-MRSI had the highest pooled specificity (90%, 95% confidence interval 56-100%). The pooled sensitivity and specificity on sextant analysis was 58% (95% confidence interval 53-64%) and 85% (95% confidence interval 82-88%), respectively. DCE MRI showed the highest pooled sensitivity: 71% (95% confidence interval 60-80%).
Conclusion: A limited number of small studies suggest that MRI can accurately detect local recurrences after EBRT and radical prostatectomy. DCE MRI is particularly accurate. The addition of MRSI to DCE MRI can significantly improve the diagnostic accuracy of local prostate cancer recurrence. The eventual role of 1H-MRSI alone remains controversial and needs to be defined further.
Copyright © 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.AJR Am J Roentgenol. 2013 Apr;200(4):W361-8. doi: 10.2214/AJR.12.9106. AJR Am J Roentgenol. 2013. PMID: 23521479
-
Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).Eur J Radiol. 2012 Apr;81(4):700-8. doi: 10.1016/j.ejrad.2011.01.095. Epub 2011 Feb 17. Eur J Radiol. 2012. PMID: 21330082 Clinical Trial.
-
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.Eur Urol. 2008 Sep;54(3):589-600. doi: 10.1016/j.eururo.2007.12.034. Epub 2007 Dec 31. Eur Urol. 2008. PMID: 18226441
-
Imaging for the Detection of Locoregional Recurrences in Biochemical Progression After Radical Prostatectomy-A Systematic Review.Eur Urol Focus. 2019 Jul;5(4):550-560. doi: 10.1016/j.euf.2017.11.001. Epub 2017 Nov 11. Eur Urol Focus. 2019. PMID: 29133278
-
The value of magnetic resonance imaging in the detection of prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels: a meta-analysis.Acad Radiol. 2014 May;21(5):578-89. doi: 10.1016/j.acra.2014.01.004. Acad Radiol. 2014. PMID: 24703470 Review.
Cited by
-
Targeting Local Recurrence After Surgery With MRI Imaging for Prostate Cancer in the Setting of Salvage Radiation Therapy.Front Oncol. 2022 Feb 15;12:775387. doi: 10.3389/fonc.2022.775387. eCollection 2022. Front Oncol. 2022. PMID: 35242702 Free PMC article. Review.
-
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.Ann Oncol. 2015 Aug;26(8):1589-604. doi: 10.1093/annonc/mdv257. Epub 2015 Jun 3. Ann Oncol. 2015. PMID: 26041764 Free PMC article.
-
Multimodality Imaging of Prostate Cancer.J Nucl Med. 2019 Oct;60(10):1350-1358. doi: 10.2967/jnumed.119.228320. Epub 2019 Sep 3. J Nucl Med. 2019. PMID: 31481573 Free PMC article. Review.
-
Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.Biomed Res Int. 2014;2014:316272. doi: 10.1155/2014/316272. Epub 2014 May 25. Biomed Res Int. 2014. PMID: 24967355 Free PMC article. Review.
-
The role of MRI in prostate cancer: current and future directions.MAGMA. 2022 Aug;35(4):503-521. doi: 10.1007/s10334-022-01006-6. Epub 2022 Mar 16. MAGMA. 2022. PMID: 35294642 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical